TBTC Study 28: evaluation of a moxifloxacin-based, isoniazid-sparing regimen for tuberculosis treatment
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2011
At a glance
- Drugs Ethambutol; Isoniazid; Moxifloxacin; Pyrazinamide; Pyridoxine; Rifampicin
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- 02 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Aug 2009 Results have been reported in the American Journal of Respiratory and Critical Care Medicine.
- 20 Sep 2007 Status changed from recruiting to in progress.